Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Celecoxib × Other solid neoplasm × Clear all

Phase

Phase 1 8 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 36 Thoracic 15 Breast 15 Head & Neck 13 CNS 11 Genitourinary 10 Gynecologic 8 Sarcoma 7 Dermatologic 3 Tumor-Agnostic 2 Other neoplasm 2 Plasma cell 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Other 1 Myeloid 1 Lymphoid 1 Endocrine 1

Conditions

Interventions

Cisplatin 42 Pemetrexed 31 Carboplatin 28 Nivolumab 21 pembrolizumab 19 Gemcitabine 19 atezolizumab 13 Etoposide 13 Injections 12 Ipilimumab 11 Cyclophosphamide 11 Radiotherapy 10 Oxaliplatin 10 Filgrastim 10 Docetaxel 10 Bevacizumab 10 tislelizumab 9 Vincristine 9 Specimen Handling 9 durvalumab 8 Paclitaxel 8 Capecitabine 8 tremelimumab 7 toripalimab 7 lenvatinib 7 Everolimus 7 spartalizumab 6 olaparib 6 niraparib 6 Vinorelbine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04469530 2026-02-27

AflacST1903

Emory University

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡